de-Miguel-Díez Javier, Lopez-de-Andres Ana, Hernandez-Barrera Valentin, Jimenez-Trujillo Isabel, Mendez-Bailon Manuel, de Miguel-Yanes Jose M, Muñoz-Rivas Nuria, Romero-Maroto Martin, Jimenez-Garcia Rodrigo
Respiratory Department, Hospital General Universitario Gregorio Marañón, Facultad de Medicina, Universidad Complutense de Madrid (UCM), Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM).
Preventive Medicine and Public Health Teaching and Research Unit, Health Sciences Faculty, Universidad Rey Juan Carlos, Alcorcón.
Medicine (Baltimore). 2019 May;98(18):e15518. doi: 10.1097/MD.0000000000015518.
To examine trends in the incidence, characteristics and outcomes, and to identify factors associated with in-hospital mortality (IHM) of patients hospitalized for primary pulmonary hypertension (PPH) in Spain (2004-2015).We included all patients hospitalized with PPH and included in the Spanish National Hospital Discharge Database.We analyzed 46,883 discharges of patients (7.14% with PPH as their primary diagnosis). Incidence rates decreased from 6.15 cases per 100,000 inhabitants in 2004-06 to 3.40 in 2013-15 (P < .001). Mean age rose from 66.43 ± 21.28 to 69.73 ± 21.12 years (P < .001) and the proportion of females increased over the study period (58.44% vs 60.71%; P < .001). Comorbidity using the Charlson Comorbidity Index (CCI) also increased with 16.07% having CCI ≥3 in 2004-06 vs 21.795 in 2013-15. Median length of hospital stay (LOHS) was 1 day longer in period 2004-06, than in 2013-15 (9 vs 8 days; P < .001). The proportion of patients who were considered a readmission and the mean costs increased from 15.7% and 3712.46&OV0556; in the first period to 17.14% and 4040.28&OV0556; in 2013-15 (P < .001). IHM increased from 8.2% in 2004-06 to 9.93% in 2013-15 (P < .001). The predictors' of IHM among PPH patients included comorbidity and use of mechanical ventilation. Primary diagnosis of PPH did not predict higher IHM (OR 1.07; 95%CI 09-1.26).Our data indicates that the incidence of hospitalizations decreased in Spain between 2004 and 2015. Parallel, LOHS also decreased during this period. By contrast, comorbidity increased over time in PPH patients, as well as readmission rates, costs and IHM.
为研究西班牙原发性肺动脉高压(PPH)住院患者的发病率、特征及转归趋势,并确定与院内死亡率(IHM)相关的因素。我们纳入了西班牙国家医院出院数据库中所有因PPH住院的患者。我们分析了46883例患者的出院情况(7.14%以PPH作为主要诊断)。发病率从2004 - 2006年的每10万居民6.15例降至2013 - 2015年的3.40例(P < 0.001)。平均年龄从66.43±21.28岁升至69.73±21.12岁(P < 0.001),且研究期间女性比例增加(58.44%对60.71%;P < 0.001)。使用Charlson合并症指数(CCI)的合并症情况也有所增加,2004 - 2006年CCI≥3的患者为16.07%,而2013 - 2015年为21.795%。2004 - 2006年的中位住院时间(LOHS)比2013 - 2015年长1天(9天对8天;P < 0.001)。再次入院患者的比例及平均费用从第一阶段的15.7%和3712.46欧元增至2013 - 2015年的17.14%和4040.28欧元(P < 0.001)。IHM从2004 - 2006年的8.2%增至2013 - 2015年的9.93%(P < 0.001)。PPH患者中IHM的预测因素包括合并症和机械通气的使用。PPH的主要诊断并不能预测更高的IHM(比值比1.07;95%置信区间0.9 - 1.26)。我们的数据表明,2004年至2015年西班牙住院率下降。与此同时,在此期间LOHS也下降。相比之下,PPH患者的合并症、再入院率、费用及IHM随时间增加。